Navigation Links
Centocor R&D and University of Michigan Forge New Model for Academic/Industry Partnerships
Date:3/19/2009

MALVERN, Pa. March 19 /PRNewswire/ -- A new joint program launched by Centocor Research and Development, Inc. and the University of Michigan provides an innovative model for industry/academic fellowship programs. Centocor designed the program to continue to build and diversify the company's pipeline of talent while supporting postdoctoral researchers in populations that are traditionally underrepresented in the science and medical communities.

"Scientific excellence and diversity are key drivers for our success as a global pharmaceutical organization. Partnering with a leading research organization to foster the training of the next generation of scientific leaders is a key part of our strategy," said Miguel Barbosa, Ph.D., vice president, Discovery Research at Centocor R&D.

The program aims to forge strong relationships with African American, Hispanic, and Native American scientists who are working in the strategic areas of focus for Centocor.

"We believe the direct ties to our research interests make this program more strategic and collaborative than traditional industry/academic fellowship programs," Barbosa said. "This strategic link will help us build strong relationships with these talented individuals thus creating a robust pipeline of potential hires."

Under the program, research proposals developed jointly by University of Michigan and Centocor scientists are submitted to and reviewed by a joint committee of Centocor and Michigan representatives, who will select projects and evaluate their progress. Postdoctoral fellows recruited by the University of Michigan have the opportunity to work at both the University and at the Centocor campus and to work through scientific challenges with a mentor at each location.

Centocor R&D selected the University of Michigan with which to pilot the program, based on the high level of productivity past research collaborations have yielded, and may expand the program in the coming years to other academic partners.

Barbosa said, "We look forward to nurturing the development of underrepresented minority post doctoral trainees from University of Michigan and potentially other top-tier research organizations into the next generation of scientific leaders."

About Centocor Research and Development, Inc.

Centocor is dedicated to the research and development of treatments for a wide range of immune-mediated inflammatory disorders, such as arthritis, and inflammatory skin diseases, and for cancer, cardiovascular and metabolic and infectious diseases. Developed primarily through monoclonal antibody technology, Centocor helps physicians deliver innovative treatments to improve human health and restore patients' quality of life.


'/>"/>
SOURCE Centocor Research and Development, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. FASgen, Inc. Announces Research and License Agreement With Centocor, Inc.
2. Biologic Drugs, Particularly Centocor/Janssen-Cilags Stelara and Abbott/Eisais Humira, will Drive the Psoriasis Drug Market to $5 Billion by 2017
3. MEDVERSATION(TM) Website Launched by Centocor to Facilitate Physician-Patient Dialogue About Drug Benefits and Risks
4. Centocor, Inc. Submits Application to FDA Requesting Approval of Golimumab for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
5. Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab
6. Western Governors University Addresses Rising Demand for Healthcare IT Professionals with B.S. in Health Informatics
7. DeVry University announces Employment Gap Scholarship program to aid displaced workers
8. University of Notre Dame Chooses Latest Technology From Carestream Molecular Imaging For Disease Research
9. University of Pennsylvania researchers find that the unexpected is a key to human learning
10. NorthShore University HealthSystem Launches Diabetes Outreach Program for Lake County's Medically Underserved
11. Dallas To Host Intensive Norvax University Insurance Agent Sales Training and Web Marketing Conference on March 26
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice ... "Film editors can give their videos a whole new perspective by using the ... of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets to ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs ... College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. ... treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has dedicated ... has implemented orthobiologic procedures as a method for treating his patients. The procedure ... doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
Breaking Medicine Technology: